Trial Profile
A phase I study for safety and tolerability in patients with retinitis pigmentosa
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs OCU 100 (Primary)
- Indications Retinitis pigmentosa
- Focus Adverse reactions
- 15 Apr 2015 New trial record